Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer

Genome Research

Volumn 20, Issue 4, 2010, Pages 440-446

  Teschendorff, Andrew E ^a   Menon, Usha ^b   Gentry Maharaj, Aleksandra ^b   Ramus, Susan J ^b   Weisenberger, Daniel J ^c   Shen, Hui ^c   Campan, Mihaela ^c   Noushmehr, Houtan ^c   Bell, Christopher G ^a   Maxwell, A Peter ^d   Savage, David A ^d   Mueller Holzner, Elisabeth ^e   Marth, Christian ^e   Kocjan, Gabrijela ^b   Gayther, Simon A ^b   Jones, Allison ^b   Beck, Stephan ^a   Wagner, Wolfgang ^f   Laird, Peter W ^c   Jacobs, Ian J ^b   Widschwendter, Martin ^b   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGING; ARTICLE; BLOOD SAMPLING; CANCER STEM CELL; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE MAPPING; GENE REPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROMOTER REGIONS, GENETIC; STEM CELLS; TUMOR MARKERS, BIOLOGICAL; VALIDATION STUDIES AS TOPIC; YOUNG ADULT;

EID: 77950650405     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.103606.109     Document Type: Article

References (41)

1. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. 1998. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58: 5489-5494.
2. Baylin SB, Ohm JE. 2006. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116.
3. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
4. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang Y, Vollmer E, et al. 2006. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 16: 383-393.
5. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekstroem TJ, Harris TB, et al. 2008. Intra-individual change over time in DNA methylation with familial clustering. JAMA 299: 2877-2883.
6. Bloushtain-Qimron N, Yao J, Snyder EL, Shipitsin M, Campbell LL,Mani SA, Hu M, Chen H, Ustyasnky V, Antosiewicz JE, et al. 2008. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci 105: 14076-14081.
7. Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W. 2010. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54-63.
8. Cai KQ, Caslini C, Capo-chichi CD, Slater C, Smith ER,Wu H, Klein-Szanto AJ, Godwin AK, Xu XX. 2009. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PLoS One 4: e6454. doi: 10.1371/journal.pone.0006454.
9. Capo-chichi CD, Roland IH, Vanderveer L, Bao R, Yamagata T, Hirai H, Cohen C, Hamilton TC, Godwin AK, Xu XX. 2003. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis. Cancer Res 63: 4967-4977.
10. Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT, Xu XX. 2006. Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene 25: 5446-5461.
11. Catalano A, Rodilossi S, Caprari P, Coppola V, Procopio A. 2005. 5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 24: 170-179.
12. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, et al. 2009. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5: e1000602. doi: 10.1371/journal.pgen.1000602.
13. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. 2009. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4: 80-93.
14. Fraga MF, Esteller M. 2007. Epigenetics and aging: The targets and the marks. Trends Genet 23: 413-418.
15. Fraga MF, Agrelo R, Esteller M. 2007. Cross-talk between aging and cancer: The epigenetic language. Ann N Y Acad Sci 1100: 60-74.
16. Hoeijmakers JH. 2009. DNA damage, aging, and cancer. N Engl J Med 361: 1475-1485.
17. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, et al. 2000. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407: 645-648.
18. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. 1994. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540.
19. Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB. 1996. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci 93: 11757-11762.
20. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, et al. 2006. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125: 301-313.
21. Leek JT, Storey JD. 2007. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3: 1724-1735.
22. Leek JT, Storey JD. 2008. A general framework for multiple testing dependence. Proc Natl Acad Sci 105: 18718-18723.
23. Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, et al. 2009. A gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: Microfibril-associated glycoprotein 2. Cancer Cell 16: 521-532.
24. Moll UM, Slade N. 2004. p63 and p73: Roles in development and tumor formation. Mol Cancer Res 2: 371-386.
25. Myatt SS, Lam EW. 2007. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7: 847-859.
26. Nakagawa H, Nuovo GJ, Zervos EE, Martin EW Jr, Salovaara R, Aaltonen LA, de la Chapelle A. 2001. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 61: 6991-6995.
27. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, et al. 2007. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242.
28. Ongenaert M, Van Neste L, De Meyer T, Menschaert G, Bekaert S, van Criekinge W. 2008. PubMeth: A cancer methylation database combining text-mining and expert annotation. Nucleic Acids Res 36: D842-D846.
29. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, et al. 2007. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236.
30. Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, et al. 2008. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer 47: 755-765.
31. So K, Tamura G, Honda T, Homma N, Waki T, Togawa N, Nishizuka S, Motoyama T. 2006. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci 97: 1155-1158.
32. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, et al. 2009. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 41: 996-1000.
33. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc Natl Acad Sci 100: 9440-9445.
34. Talos F, Nemajerova A, Flores ER, Petrenko O, Moll UM. 2007. p73 suppresses polyploidy and aneuploidy in the absence of functional p53. Mol Cell 27: 647-659.
35. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, Jones A, Lechner M, Beck S, Jacobs I, et al. 2009. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 4: e8274. doi: 10.1371/journal.pone.0008274.
36. Truty MJ, Lomberk G, Fernandez-Zapico ME, Urrutia R. 2009. Silencing of the transforming growth factor-β (TGFβ) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFβ signaling. J Biol Chem 284: 6291-6300.
37. Wakana K, Akiyama Y, Aso T, Yuasa Y. 2006. Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis. Cancer Lett 241: 281-288.
38. Weisenberger DJ, den Berg DV, Pan F, Berman BP, Laird PW. 2008. Comprehensive DNA methylation analysis on the Illumina Infinium assay platform. Technical report. Illumina, Inc., San Diego. http://www.illumina. com/Documents/products/appnotes/appnote-infinium-methylation.pdf.
39. Widschwendter M, Jiang G, Woods C, Müller HM, Fiegl H, Goebel G, Marth C, Mueller-Holzner E, Zeimet AG, Laird PW, et al. 2004. DNA hypomethylation and ovarian cancer biology. Cancer Res 64: 4472-4480.
40. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, et al. 2007. Epigenetic stem cell signature in cancer. Nat Genet 39: 157-158.
41. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et al. 2007. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947.